Ian M. Devonshire

Ian M. Devonshire

Auto-generated profile, based on publicly available information

Ian M. Devonshire

Queen’s Medical Centre

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2012 in NeuroImage
Verified
Journal Article
Closed access
IDIan M. Devonshire
Ian M. Devonshire
NPNikos G. Papadakis
Nikos G. Papadakis
MPMichael Port
Michael Port
JBJason Berwick
Jason Berwick
AKAneurin J. Kennerley
Aneurin J. Kennerley
POPaul G. Overton
Paul G. Overton

1 August 2010 in The Neuroscientist
Verified
Journal Article
Closed access
IDIan M. Devonshire
Ian M. Devonshire
Eleanor J DommettEleanor J Dommett
Eleanor J Dommett
As a relatively young science, neuroscience is still finding its feet in potential collaborations with other disciplines. One such discipline is education, with the field of neuroeducation being on the horizon since the 1960s. However, although its achievements are now growing, the partnership has not been as successful as first hopes suggested it should be. Here the authors discuss the theoretical barriers and potential solutions to this, which have been suggested previously, with particular focus on levels of research in neuroscience and their applicability to education. Moreover, they propose that these theoretical barriers are driven and maintained by practical barriers surrounding common language and research literacy. They propose that by overcoming these practical barriers through appropriate training and shared experience, neuroeducation can reach its full potential.

14 July 2010 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
IDIan M. Devonshire
Ian M. Devonshire
TGThomas H. Grandy
Thomas H. Grandy
Eleanor J DommettEleanor J Dommett
Eleanor J Dommett
SGSusan A. Greenfield
Susan A. Greenfield

1 January 2014 in Pain
Verified
Journal Article
Open access
CKCharlie H.T. Kwok
Charlie H.T. Kwok
IDIan M. Devonshire
Ian M. Devonshire
ABAndrew J. Bennett
Andrew J. Bennett
GHGareth J. Hathway
Gareth J. Hathway
Significant opioid-dependent changes occur during the fourth postnatal week in supraspinal sites (rostroventral medulla [RVM], periaqueductal grey [PAG]) that are involved in the descending control of spinal excitability via the dorsal horn (DH). Here we report developmentally regulated changes in the opioidergic signalling within the PAG and DH, which further increase our understanding of pain processing during early life. Microinjection of the μ-opioid receptor (MOR) agonist DAMGO (30 ng) into the PAG of Sprague-Dawley rats increased spinal excitability and lowered mechanical threshold to noxious stimuli in postnatal day (P)21 rats, but had inhibitory effects in adults and lacked efficacy in P10 pups. A tonic opioidergic tone within the PAG was revealed in adult rats by intra-PAG microinjection of CTOP (120 ng, MOR antagonist), which lowered mechanical thresholds and increased spinal reflex excitability. Spinal administration of DAMGO inhibited spinal excitability in all ages, yet the magnitude of this was greater in younger animals than in adults. The expression of MOR and related peptides were also investigated using TaqMan real-time polymerase chain reaction and immunohistochemistry. We found that pro-opiomelanocortin peaked at P21 in the ventral PAG, and MOR increased significantly in the DH as the animals aged. Enkephalin mRNA transcripts preceded the increase in enkephalin immunoreactive fibres in the superficial dorsal horn from P21 onwards. These results illustrate that profound differences in the endogenous opioidergic signalling system occur throughout postnatal development.

1 December 2012 in Journal of Neurophysiology
Verified
Journal Article
Closed access
PDF file
TGT. H. Grandy
T. H. Grandy
SGS. A. Greenfield
S. A. Greenfield
IDI. M. Devonshire
I. M. Devonshire
In the current study, we investigated pharmacological side effects and signal-to-noise ratios (SNRs) of two commonly used voltage-sensitive dyes (VSDs): the blue dye RH-1691 (1 mg/ml) and the red dye di-4-ANEPPS (0.1 mg/ml), applied in vivo to the rat barrel cortex. Blue dyes are often favored over red dyes in in vivo studies due to their apparent superior SNR, partly because their fluorescence spectrum is farther away from the hemoglobin absorption spectrum, making them less prone to heartbeat-associated brain-pulsation artifacts (BPA). We implemented a previously reported template-based BPA removal algorithm and evaluated its applicability to di-4-ANEPPS before comparing characteristics of the two dyes. Somatosensory-evoked potentials (SEPs) were also recorded. Whereas SEPs recorded before and after application of di-4-ANEPPS failed to exhibit demonstrable differences, RH-1691 caused a significant and prolonged increase in SEP amplitude for several hours. In contrast, neither dye influenced the spontaneous cortical activity as assessed by the spectral content of the EEG. Both dyes turned out to be strikingly similar with respect to changes in fractional fluorescence as a function of SEP response amplitude, as well as regarding shot noise characteristics after removal of the BPA. Thus there is strong evidence that the increased SNR for RH-1691 is a consequence of an artificially increased signal. When applying an appropriate BPA removal algorithm, di-4-ANEPPS has proven to be suitable for single-trial in vivo VSD imaging (VSDI) and produces no detectable neurophysiological changes in the system under investigation. Taken together, our data argue for a careful re-evaluation of pharmacological side effects of RH-1691 and support the applicability of di-4-ANEPPS for stable single-trial in vivo VSDI recordings.

1 September 2013 in Trends in Neuroscience and Education
Verified
Journal Article
Closed access
Eleanor J DommettEleanor J Dommett
Eleanor J Dommett
IDIan M. Devonshire
Ian M. Devonshire
ESEmma Sewter
Emma Sewter
SGSusan A. Greenfield
Susan A. Greenfield